article thumbnail

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent

Fierce Pharma

UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent. Wed, 11/30/2022 - 10:55.

article thumbnail

Dipane Tablets-Uses, Benefits & Side Effects (2022)

Teachntest

Advertisement Dipane Tablets Uses, Benefits & Side Effects Dipane Tablet is a pain-relieving medicine containing Diclofenac and Paracetamol. The Dipane Tablet must … Dipane Tablets-Uses, Benefits & Side Effects (2022) Read More »

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

O2 Tablets- Uses, Benefits and Side Effects (2022)

Teachntest

It’s best to take an O2 Tablet … O2 Tablets- Uses, Benefits and Side Effects (2022) Read More » It works well to treat a wide variety of bacterial infections, including those in the teeth, lungs, digestive tract, urinary tract, and genital tract.

article thumbnail

Preventative approach could reduce immunotherapy side effects

European Pharmaceutical Review

Immunotherapy drugs like teclistamab can result in potentially fatal side effects, including CRS and immune cell-associated neurotoxicity syndrome (ICANS). In 2022, the drug was approved by the US Food and Drug Administration (FDA) for these patients. We are going with full steam into an era of immunotherapy.”

article thumbnail

Bifilac Tablet Uses, Benefits and Side Effects (2022)

Teachntest

Bifilac, Pre & probiotics will help to … Bifilac Tablet Uses, Benefits and Side Effects (2022) Read More »

article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. The post A realistic view of healthcare in 2022. Here are things I believe are more realistic.

article thumbnail

EMA human medicines committee (CHMP) highlights, November 2022

European Pharmaceutical Review

The CHMP endorsed measures recommended by the EMA Pharmacovigilance Risk Assessment Committee (PRAC), to minimise the risk of serious side effects (cardiovascular conditions, blood clots, cancer and serious infections) of janus kinase (JAK) inhibitors for treating several chronic inflammatory disorders. 5 in children five to 11 years.